These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38910744)

  • 61. Pregnancy-associated atypical hemolytic uremic syndrome. Case report.
    Barrera-Hoffmann C; Mariaca-Ortíz Y; Ruiz-Villa JG; Cuevas-Cruz LE; López-Mendoza MDR; Briones-Garduño JC
    J Obstet Gynaecol Res; 2024 Jul; 50(7):1268-1272. PubMed ID: 38720638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.
    Kurian CJ; French Z; Kukulich P; Lankiewicz M; Ghimire S; Maarouf OH; Rizk S; Rhoades R
    J Med Case Rep; 2021 Dec; 15(1):587. PubMed ID: 34903272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of von Willebrand factor in thrombotic microangiopathy.
    Noone DG; Riedl M; Licht C
    Pediatr Nephrol; 2018 Aug; 33(8):1297-1307. PubMed ID: 28748411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
    Rubio-Haro R; Quesada-Carrascosa M; Hernández-Laforet J; Ferrer Gómez C; De Andrés J
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar; 69(3):179-182. PubMed ID: 35283062
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.
    Ferrer F; Roldão M; Figueiredo C; Lopes K
    Nephron; 2022; 146(2):185-189. PubMed ID: 34724668
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Complement-mediated hemolytic uremic syndrome: a diagnostic approach].
    Wieliczko M; Twardowska-Kawalec M
    Wiad Lek; 2019; 72(11 cz 2):2239-2244. PubMed ID: 31860845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome.
    Banjongjit A; Kittanamongkolchai W; Kanjanabuch T
    Nephron; 2023; 147(11):701-706. PubMed ID: 37611541
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of pediatric hemolytic uremic syndrome.
    Gülhan B; Özaltın F; Fidan K; Özçakar ZB; Söylemezoğlu O
    Turk J Pediatr; 2024; 66(1):1-16. PubMed ID: 38523374
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postoperative Atypical Hemolytic Uremic Syndrome in a 67-Year-Old Woman Associated with Hemolytic Anemia, Thrombocytopenia, and Acute Renal Failure.
    Chowdhury A; Griffith MP; Busse E; Pasha AK
    Am J Case Rep; 2020 Dec; 21():e925662. PubMed ID: 33335086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thrombotic microangiopathy.
    Pisoni R; Remuzzi G
    Eur J Intern Med; 2000 Jun; 11(3):135-139. PubMed ID: 10854818
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still's Disease.
    Khattab A; Yellala A; Mamadgi J; Patruni S; Kaplan R
    J Hematol; 2019 Jun; 8(2):64-67. PubMed ID: 32300446
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
    Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M
    CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.
    Wada H; Matsumoto T; Suzuki K; Imai H; Katayama N; Iba T; Matsumoto M
    Thromb J; 2018; 16():14. PubMed ID: 30008620
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X; Li J; Zhan X; Tu L; Huang H; Wang Y
    J Med Case Rep; 2022 Mar; 16(1):101. PubMed ID: 35241161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.